David John Garry, DO - Medicare Obstetrics/gynecology in East Setauket, NY

David John Garry, DO is a medicare enrolled "Obstetrics & Gynecology - Maternal & Fetal Medicine" physician in East Setauket, New York. He went to Philadelphia College Of Osteopathic Medicine and graduated in 1989 and has 35 years of diverse experience with area of expertise as Obstetrics/gynecology. He is a member of the group practice University Associates In Obstetrics And Gynecology University Faculty and his current practice location is 6 Technology Dr, East Setauket, East Setauket, New York. You can reach out to his office (for appointments etc.) via phone at (631) 444-4686.

David John Garry is licensed to practice in New York (license number 184327) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1124117650.

Contact Information

David John Garry, DO
6 Technology Dr, East Setauket,
East Setauket, NY 11733-4079
(631) 444-4686
(631) 444-4622



Physician's Profile

Full NameDavid John Garry
GenderMale
SpecialityObstetrics/gynecology
Experience35 Years
Location6 Technology Dr, East Setauket, New York
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • David John Garry attended and graduated from Philadelphia College Of Osteopathic Medicine in 1989
  NPI Data:
  • NPI Number: 1124117650
  • Provider Enumeration Date: 10/12/2006
  • Last Update Date: 09/01/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 6002861994
  • Enrollment ID: I20050314000669

Medical Identifiers

Medical identifiers for David John Garry such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124117650NPI-NPPES
01706376MedicaidNY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207VM0101XObstetrics & Gynecology - Maternal & Fetal Medicine 184327 (New York)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Associates In Obstetrics And Gynecology University Faculty903200104593

News Archive

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.

SNP biomarker could reduce guesswork associated with prescribing drugs

A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.

New microbicide gel reduces woman's risk of being infected with HIV, genital herpes

Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce a woman's risk of being infected with HIV and genital herpes

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. David John Garry allows following entities to bill medicare on his behalf.
Entity NameMontefiore Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063525152
PECOS PAC ID: 3779496021
Enrollment ID: O20031113000235

News Archive

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.

SNP biomarker could reduce guesswork associated with prescribing drugs

A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.

New microbicide gel reduces woman's risk of being infected with HIV, genital herpes

Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce a woman's risk of being infected with HIV and genital herpes

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.

Read more Medical News

› Verified 6 days ago

Entity NameUniversity Associates In Obstetrics & Gynecology University Faculty P
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538114723
PECOS PAC ID: 9032001045
Enrollment ID: O20040325001243

News Archive

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.

SNP biomarker could reduce guesswork associated with prescribing drugs

A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.

New microbicide gel reduces woman's risk of being infected with HIV, genital herpes

Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce a woman's risk of being infected with HIV and genital herpes

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David John Garry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
David John Garry, DO
Po Box 1554,
Stony Brook, NY 11790-0988

Ph: (631) 444-0650
David John Garry, DO
6 Technology Dr, East Setauket,
East Setauket, NY 11733-4079

Ph: (631) 444-4686

News Archive

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.

SNP biomarker could reduce guesswork associated with prescribing drugs

A tiny gene mutation in human liver cells could one day influence how high or low a dose patients need of about half of the clinically used drugs on the market, new research suggests.

New microbicide gel reduces woman's risk of being infected with HIV, genital herpes

Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce a woman's risk of being infected with HIV and genital herpes

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.

Read more News

› Verified 6 days ago


Obstetrics & Gynecology Doctors in East Setauket, NY

James Bernasko, M.D
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 4 Technology Dr, Stony Brook University Physicians, East Setauket, NY 11733
Phone: 631-444-4686    
Dr. Todd R Griffin, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 6 Technology Dr, East Setauket, NY 11733
Phone: 631-444-4686    
Dr. Melissa Strafford, M.D.
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 4 Technology Dr, East Setauket, NY 11733
Phone: 631-444-4686    
Dr. Cecilia Avila, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 6 Technology Dr, East Setauket, NY 11733
Phone: 631-444-4686    
Philip Schoenfeld, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 100 S Jersey Ave Unit 16, East Setauket, NY 11733
Phone: 631-689-6400    
Dr. Jennifer Marie Blaber, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 140 N Belle Mead Ave, East Setauket, NY 11733
Phone: 631-444-4686    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.